Zelsuvmi Kit
Product Images NDC 83787-103

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Zelsuvmi (NDC 83787-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lnhc, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Berdazimer 3)

Chemical structure diagram showing siloxane-based molecular structures likely related to the active ingredient berdazimer in the product ZELSUVMI. The image depicts silicon (Si) atoms connected with oxygen (O) atoms and associated chemical groups, including a sodium salt form and methylamine-related components.*

FDA Label Image

Carton (Carton Image)

The image shows the packaging label for ZELSUVMI (berdazimer) topical gel, 10.3%, a prescription drug kit marketed by LNHC, Inc. The label contains detailed storage, dosage, and ingredient information, including the composition of two tubes A and B in the kit. It specifies that each gram contains 103 mg berdazimer and emphasizes use instructions and warnings.*

FDA Label Image

Ifu Page 1 (Ifu 1)

Instructions for use of ZELSUVMI (berdazimer) topical gel 10.3% include preparation and application guidelines. The kit contains two tubes (Tube A with berdazimer gel and Tube B with hydrogel) and a dosing guide. It emphasizes topical use, avoiding contact with eyes, mouth, or open wounds, and mixing gels only on the dosing guide before application. Additional instructions cover dosing guide use and preparing tubes for application.*

FDA Label Image

Ifu Step 1 (Ifu 2)

Instructions for use of ZELSUVMI (berdazimer) topical gel, 10.3% kit, manufactured by LNHC, Inc. The panel shows step-by-step guidance on washing hands, dispensing gels from two tubes onto a dosing guide, mixing the gels, applying the mixed gel to molluscum bumps, cleaning the dosing guide, storing the product, and disposing of empty tubes. Illustrations accompany each step.*

FDA Label Image

Tube A Carton (Tube A Carton)

Flat layout of the ZELSUVMI berdazimer kit carton packaging by LNHC, Inc. The label shows the product name, kit designation as Tube A (1 of 2), net weight of 14g, and directions for use. Blue and white color scheme with sections marked for pharmacode, Braille, expiration, lot, and other coding areas. Dimensions and folding guides are indicated for carton assembly.*

FDA Label Image

Tube A Tube (Tube A Tube)

Label image of ZELSUVMI kit packaging for berdazimer 22.7%, showing detailed tube graphics including dosage and usage instructions. The label includes storage guidelines, manufacturer information, and specifies that the product is for topical use only. The tube measures approximately 2.3562 inches in diameter and 4 inches in length, primarily blue with black and white text panels, produced by LNHC, Inc.*

FDA Label Image

Tube B Carton (Tube B Carton)

Packaging label artwork for ZELSUVMI kit containing berdazimer by LNHC, Inc. The layout shows folding and cutting lines for the box with yellow and white color blocks. The label includes text for Tube B (2 of 2), net weight 17g, storage instructions, and manufacturer details. The design specifies print colors magenta, yellow, black, and dimensions 35x28x112 mm.*

FDA Label Image

Tube B Tube (Tube B Tube)

Packaging label for ZELSUVMI berdazimer hydrogel tube, marked as Tube B (2 of 2) in a kit. The label specifies a net weight of 17 g and includes storage instructions and manufacturing information, indicating the tube is for topical use only and must be mixed with Tube A before use. The labeler is LNHC, Inc., and the tube design uses yellow (PMS 116) and black colors.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.